GEN Exclusives

More »

GEN News Highlights

More »
Aug 9, 2007

Tripos Inks Library Analysis Agreement with Elan

  • Tripos Discovery Research (TDR) will assist Elan Pharmaceuticals in analyzing and enhancing the diversity of its small molecule screening collection.

    TDR will perform computational clustering of key subsets and determine optimal areas for expansion. The company also will provide high-throughput quality control analyses of legacy compounds via mass spectrometry.

    Applying its computational design and therapeutic medicinal chemistry tools, TDR says that it is able to reduce drug discovery timelines by up to 30%.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?